Introduction
Methods
Sampling
Questionnaire
Classification
Data processing and statistical methods
Ethical issues
Results
Prevalence of pure menstrual migraine and menstrually related migraine
Age (years) | ||||
---|---|---|---|---|
30–34 | 35–39 | 40–44 | All | |
n = 3,245 (%) | n = 3,410 (%) | n = 3,521 (%) | n = 10,176 (%) | |
Prevalence among all women | ||||
All migraine | 33.3 (31.4–34.6) | 35.1 (33.6–36.8) | 36.1 (34.5–37.7) | 34.9 (34.0–35.8) |
Pure menstrual migraine | 2.0 (1.6–2.6) | 2.8 (2.3–3.3) | 3.2 (2.8–3.8) | 2.7 (2.4–3.0) |
Menstrually related migraine | 4.5 (3.8–5.2) | 4.7 (4.0–5.4) | 4.7 (4.0–5.4) | 4.6 (4.2–5.0) |
All menstrual migraine | 6.6 (5.8–7.4) | 7.5 (7.0–8.4) | 7.8 (6.9–8.7) | 7.3 (6.8–7.8) |
Prevalence among migraineurs | ||||
Pure menstrual migraine | 6.3 (4.9–7.8) | 8.0 (6.5–9.5) | 8.7 (7.2–10.2) | 7.7 (6.9–8.7) |
Menstrually related migraine | 13.5 (11.5–15.5) | 13.3 (11.3–15.3) | 13.0 (11.0–15.0) | 13.2 (12.1–14.3) |
All menstrual migraine | 19.8 (17.4–22.2) | 21.4 (19.1–23.7) | 21.7 (19.4–24.0) | 20.9 (19.7–22.4) |
Discussion
Strengths and limitations
Results
Author | Study population | Participants | Design | Definition of PMM and MRM | Prevalence of PMM among migraineurs | Prevalence of MRM among migraineurs |
---|---|---|---|---|---|---|
Norway, Vetvik and Russell [This study] | General population | n = 10,176 30–44 years | Retrospective questionnaire | ICHD 2, Appendix | PMM: 7.7% | MRM: 13.2% |
USA, Tepper et al. [30] | OB/GYN clinic | n = 610 Mean 32 years | Physician interview and prospective diary | ICHD 2, Appendix | PMM: 12.1% | MRM: 10.0% |
Norway, Bekkelund et al. [32] | Clinic population (newspaper advertisement) | n = 62 16–46 years, mean 36.2 | Telephone interview and prospective diary of 12 months | ICHD 2, Appendix | Menstrual migraine (not divided into PMM and MRM) 46.7% | |
The Netherlands, Couturier et al. [15] | General population | n = 1,181 13–55 years | Retrospective questionnaire | PMM: migraine attack exclusively on days −2 to +2 MRM: attacks on days −2 to +2 and at other times | PMM: 0.85% In the general population, not among migraineurs | MRM: 3% In the general population, not among migraineurs |
Sweden, Mattsson [31] | General population | n = 728 Age 40–74 years | Retrospective physician interview and questionnaire | >75% of attack of MO within the days 1 ± 2 | Menstrual migraine (not divided into PMM and MRM) 21% | |
Serbia, Dzoljic et al. [12] | Female students | n = 1,943 18–28 years | Retrospective questionnaire | PMM: migraine attack exclusively on day 1 ± 2 MRM: aggravated during menstruation | PMM 12% | MRM 68% |
Italy, Cupini et al. [11] | Headache clinic | n = 154 women with MO | Prospective diary of 3 months | PMM: migraine attack exclusively from 2 days before to 3 days after menstruation MRM: not defined | PMM 13.6% | MRM 56.4% |
Denmark, Russell et al. [2] | General population | n = 1,000 40 years | Physician interview and questionnaire | Attacks occurring ±48 h from the start of menstruation in >90% of the cycles | Menstrual migraine (not divided into PMM and MRM) 24.8% | |
Italy, Granella et al. [9] | Headache clinic | n = 1,300 | Retrospective | PMM: Migraine attacks on day −3 to +3 (>90%attacks in perimenstrual period) MRM: attacks occurred predominantly in this period | PMM 9.1% | MRM 50.8% |
18–70 years | ||||||
UK, Beckham et al. [13] | Headache clinic | n = 14 26–46 years, mean 35 | Prospective diary of 1 month and physician interview | PMM: migraine attack on day −3 to +3 MRM: the mean of the total headache activity was greater during the premenstrual and menstrual phases compared to the ovulatory and luteal phases | PMM 7.1% | MRM 71.4% |
UK, MacGregor et al. [10] | Headache clinic | n = 55 17–50 years, mean 35.8 | Prospective diary of three cycles | PMM: migraine attack exclusively on day 1 ± 2 MRM: increased number of attacks within this period | PMM 7.2% | MRM 34.5% |